Latest News

HHS on a phone | Image credit: Timon -
HHS Praises Biosimilars Savings but Opportunities to Reduce Part B Spending Remain

November 28th 2023

Although biosimilars have already generated savings for Medicare Part B programs and beneficiaries, opportunities for substantial reductions in spending remain, according to a report from the HHS.

eye on pharma banner
Eye on Pharma: Adalimumab Updates; New Eylea Biosimilar Lawsuit; Canada Gains Stelara Biosimilar

November 22nd 2023

Digestive tract. | Image Credit: sdecoret -
Study Confirms Safety and Efficacy of Adalimumab Biosimilar HS016 in IBD

November 21st 2023

Poland flag | Image credit: Maxim -
Public Payer in Poland Saves €243 Million by Using Biosimilar TNF Inhibitors

November 11th 2023

digestive tract | Image credit: Aliaksandr Marko -
Real-World Data Confirm Safety, Efficacy of CT-P13 in Inflammatory Diseases

November 9th 2023

Video Series
Video Interviews
CFB podcast banner
cfb podcast banner
"When Choice Arrives: Competition & Consequences" written over a bright blue syringe with the AJMC/The Center for Biosimilars logo in the bottom right corner

More News

© 2023 MJH Life Sciences

All rights reserved.